Manulife (Manufacturers Life Insurance)’s Phibro Animal Health PAHC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $304K | Sell |
5,500
-592
| -10% | -$28.2K | ﹤0.01% | 2329 |
|
|
2025
Q4 | $228K | Sell |
6,092
-698
| -10% | -$28.4K | ﹤0.01% | 2465 |
|
|
2025
Q3 | $275K | Buy |
+6,790
| New | +$224K | ﹤0.01% | 2427 |
|
|
2022
Q1 | – | Sell |
-11,990
| Closed | -$245 | – | 3160 |
|
|
2021
Q4 | $245 | Sell |
11,990
-262
| -2% | -$5.59K | ﹤0.01% | 2768 |
|
|
2021
Q3 | $264K | Sell |
12,252
-558
| -4% | -$13.4K | ﹤0.01% | 2774 |
|
|
2021
Q2 | $370K | Sell |
12,810
-918
| -7% | -$24.8K | ﹤0.01% | 2645 |
|
|
2021
Q1 | $335K | Buy |
13,728
+650
| +5% | +$14.7K | ﹤0.01% | 2546 |
|
|
2020
Q4 | $254K | Buy |
13,078
+184
| +1% | +$3.38K | ﹤0.01% | 2616 |
|
|
2020
Q3 | $224K | Hold |
12,894
| – | – | ﹤0.01% | 2491 |
|
|
2020
Q2 | $330K | Sell |
12,894
-910
| -7% | -$22.6K | ﹤0.01% | 2190 |
|
|
2020
Q1 | $334K | Buy |
13,804
+667
| +5% | +$16.3K | ﹤0.01% | 2033 |
|
|
2019
Q4 | $326K | Sell |
13,137
-224
| -2% | -$5.2K | ﹤0.01% | 2288 |
|
|
2019
Q3 | $281K | Sell |
13,361
-266
| -2% | -$7.29K | ﹤0.01% | 2361 |
|
|
2019
Q2 | $433K | Buy |
13,627
+5,483
| +67% | +$172K | ﹤0.01% | 2137 |
|
|
2019
Q1 | $269K | Buy |
8,144
+1,183
| +17% | +$36.8K | ﹤0.01% | 2296 |
|
|
2018
Q4 | $224K | Sell |
6,961
-7,099
| -50% | -$268K | ﹤0.01% | 2258 |
|
|
2018
Q3 | $604K | Sell |
14,060
-1,605
| -10% | -$75.8K | ﹤0.01% | 2143 |
|
|
2018
Q2 | $722K | Buy |
15,665
+74
| +0.5% | +$3.28K | ﹤0.01% | 2101 |
|
|
2018
Q1 | $620K | Sell |
15,591
-323
| -2% | -$12K | ﹤0.01% | 2181 |
|
|
2017
Q4 | $534K | Buy |
15,914
+593
| +4% | +$21.1K | ﹤0.01% | 2277 |
|
|
2017
Q3 | $567K | Sell |
15,321
-44
| -0.3% | -$1.65K | ﹤0.01% | 2187 |
|
|
2017
Q2 | $569K | Sell |
15,365
-301
| -2% | -$9.83K | ﹤0.01% | 2192 |
|
|
2017
Q1 | $440K | Buy |
15,666
+1,772
| +13% | +$50K | ﹤0.01% | 2292 |
|
|
2016
Q4 | $407K | Sell |
13,894
-240
| -2% | -$6.55K | ﹤0.01% | 2254 |
|
|
2016
Q3 | $385K | Buy |
14,134
+61
| +0.4% | +$1.38K | ﹤0.01% | 2248 |
|
|
2016
Q2 | $262K | Buy |
14,073
+1,785
| +15% | +$37.2K | ﹤0.01% | 2502 |
|
|
2016
Q1 | $327K | Sell |
12,288
-22
| -0.2% | -$631 | ﹤0.01% | 2254 |
|
|
2015
Q4 | $371 | Hold |
12,310
| – | – | ﹤0.01% | 2211 |
|
|
2015
Q3 | $390 | Buy |
12,310
+271
| +2% | +$9.89K | ﹤0.01% | 2164 |
|
|
2015
Q2 | $469 | Buy |
12,039
+1,463
| +14% | +$50.5K | ﹤0.01% | 2163 |
|
|
2015
Q1 | $375 | Buy |
10,576
+314
| +3% | +$10.1K | ﹤0.01% | 2275 |
|
|
2014
Q4 | $324 | Buy |
10,262
+520
| +5% | +$14.4K | ﹤0.01% | 2294 |
|
|
2014
Q3 | $219 | Sell |
9,742
-653
| -6% | -$13.1K | ﹤0.01% | 2579 |
|
|
2014
Q2 | $228K | Buy |
+10,395
| New | +$198K | ﹤0.01% | 2622 |
|
Other funds holding PAHC
VCM
VPM
N
Manulife (Manufacturers Life Insurance)'s PAHC Position: Q1 2026 in Review
Manulife (Manufacturers Life Insurance) reduced its Phibro Animal Health (PAHC) stake by 9.7% in Q1 2026, selling an estimated $28.2K and leaving 5,500 shares worth $304K. The position accounts for ﹤0.01% of the portfolio, ranked #2329.
Manulife (Manufacturers Life Insurance) first reported a position in PAHC in Q2 2014 and has held it in 34 quarters since. The position peaked at $722K in Q2 2018. 257 funds tracked by Wall St. Rank hold PAHC as of Q1 2026.
- Manulife (Manufacturers Life Insurance) held 5,500 shares of Phibro Animal Health worth $304K as of Q1 2026.
- Manulife (Manufacturers Life Insurance) sold 592 Phibro Animal Health shares in Q1 2026, an estimated $28.2K.
- Phibro Animal Health made up ﹤0.01% of Manulife (Manufacturers Life Insurance)'s portfolio in Q1 2026, its #2329 holding.
- Manulife (Manufacturers Life Insurance) first reported a position in Phibro Animal Health in Q2 2014 and has held it in 34 quarters since.
- Manulife (Manufacturers Life Insurance)'s Phibro Animal Health position peaked at $722K in Q2 2018.
- 257 funds tracked by Wall St. Rank held Phibro Animal Health as of Q1 2026.
Based on Manulife (Manufacturers Life Insurance)'s 13F filing for Q1 2026, filed 15 May 2026.